Awards for “ACTELION PHARMACEUTICALS US, INC”
25 awards on this page · sorted by amount · page 6
| Award ID | Recipient | Awarding agency | Amount | Start | End | NAICS | Description |
|---|---|---|---|---|---|---|---|
| VA673A10219 | ACTELION PHARMACEUTICALS US, INC. | Department of Veterans Affairs | $63.88K | 2011-02-25 | 2012-07-12 | 325412 | MEDICAL DRUGS |
| VA26012F0038 | ACTELION PHARMACEUTICALS US, INC. | Department of Veterans Affairs | $63.18K | 2011-10-01 | 2014-01-31 | 325412 | BOSENTAN MEDICATION FOR 2 PATIENTS FOR FY12 |
| 36C26024F0037 | ACTELION PHARMACEUTICALS US, INC. | Department of Veterans Affairs | $63.11K | 2023-10-01 | 2024-09-30 | 325412 | VELETRI |
| 36C26025F0001 | ACTELION PHARMACEUTICALS US, INC. | Department of Veterans Affairs | $62.79K | 2024-10-01 | 2025-09-30 | 325412 | VELETRI BULK |
| 15B50926F00000148 | ACTELION PHARMACEUTICALS US, INC. | Department of Justice | $61.99K | 2026-02-01 | 2026-02-28 | 325412 | FY26-PHARMACY ACTELION (UPTRAVI/OPSUMIT) FEBRUARY |
| 15B50926F00000100 | ACTELION PHARMACEUTICALS US, INC. | Department of Justice | $61.99K | 2026-09-01 | 2026-09-30 | 325412 | FY26-PHARMACY ACTELION (UPTRAVI/OPSUMIT) SEPTEMBER |
| 15B50926F00000099 | ACTELION PHARMACEUTICALS US, INC. | Department of Justice | $61.99K | 2026-08-01 | 2026-08-31 | 325412 | FY26-PHARMACY ACTELION (UPTRAVI/OPSUMIT) AUGUST |
| 15B50926F00000098 | ACTELION PHARMACEUTICALS US, INC. | Department of Justice | $61.99K | 2026-07-01 | 2026-07-31 | 325412 | FY26-PHARMACY ACTELION (UPTRAVI/OPSUMIT) JULY |
| 15B50926F00000095 | ACTELION PHARMACEUTICALS US, INC. | Department of Justice | $61.99K | 2026-04-01 | 2026-04-30 | 325412 | FY26-PHARMACY APRIL |
| 15B50926F00000064 | ACTELION PHARMACEUTICALS US, INC. | Department of Justice | $61.99K | 2026-03-01 | 2026-03-31 | 325412 | FY26-PHARMACY MARCH |
| 15B50926F00000054 | ACTELION PHARMACEUTICALS US, INC. | Department of Justice | $61.99K | 2026-02-28 | 2026-02-28 | 325412 | FY26-PHARMACUTICALS |
| 15B50526F00000082 | ACTELION PHARMACEUTICALS US, INC. | Department of Justice | $61.99K | 2026-01-31 | 2026-01-31 | 325412 | ACTELION ORDER FOR FMC FTW |
| 36C26020F0024 | ACTELION PHARMACEUTICALS US, INC. | Department of Veterans Affairs | $61.73K | 2019-10-01 | 2020-09-30 | 325412 | ACCREDO |
| VA26018J2277 | ACTELION PHARMACEUTICALS US, INC. | Department of Veterans Affairs | $61.68K | 2017-10-01 | 2018-09-30 | 325412 | DRUG: VELETRI (EPOPROSTENOL) 1.5MG, VIAL, INJ, NDC #66215-0402-01 - BULD FUNDING FOR FY2018 |
| VA523A10254 | ACTELION PHARMACEUTICALS US, INC. | Department of Veterans Affairs | $61.48K | 2010-12-31 | 2012-02-29 | 325412 | YEARLY CONTRACT FOR SOLE SOURCE NAC RX PROVIDER FOR LIFE SUSTAINING MEDICATION FOR ONE PATIENT. |
| 36C26022F0005 | ACTELION PHARMACEUTICALS US, INC. | Department of Veterans Affairs | $61.05K | 2021-10-01 | 2022-09-30 | 325412 | VELETRI |
| 36C26019N0057 | ACTELION PHARMACEUTICALS US, INC. | Department of Veterans Affairs | $60.84K | 2018-10-01 | 2019-09-30 | 325412 | BULK FUNDED FY19 PO FOR ACCREDO/VELETRI PHARMACY FOR THE BOISE, ID VAMC. |
| VA26017J3075 | ACTELION PHARMACEUTICALS US, INC. | Department of Veterans Affairs | $60.74K | 2016-09-29 | 2017-09-30 | 325412 | VELETRI 1.5 |
| VA26016F4731 | ACTELION PHARMACEUTICALS US, INC. | Department of Veterans Affairs | $59.88K | 2015-10-01 | 2016-09-30 | 325412 | VELETRI |
| VA26217J7442 | ACTELION PHARMACEUTICALS US, INC. | Department of Veterans Affairs | $59.34K | 2017-10-01 | 2018-09-30 | 325412 | BOSENTAN PHARMACEUTICAL SPECIALTY DRUG POP: 10/1/2017 THRU 9/30/2018 |
| VA26217F0203 | ACTELION PHARMACEUTICALS US, INC. | Department of Veterans Affairs | $59.13K | 2016-10-01 | 2017-09-30 | 325412 | MEDS |
| VA26117F0273 | ACTELION PHARMACEUTICALS US, INC. | Department of Veterans Affairs | $59.13K | 2016-10-01 | 2020-05-01 | 325412 | BOSENTAN(TRACLEER) 125 MG TAB, 60 COUNT. |
| 36C24718K0168 | ACTELION PHARMACEUTICALS US, INC. | Department of Veterans Affairs | $59.13K | 2016-10-01 | 2017-09-30 | 325412 | EXPRESS REPORT: FOR PHARMACY ORDERING OFFICER ORDERS FOR PHARMACEUTICALS FOR FY17 |
| 15B50524F00000099 | ACTELION PHARMACEUTICALS US, INC. | Department of Justice | $58.65K | 2024-03-22 | 2024-03-31 | 325412 | CURASCRIPT, OPSUMIT 10MG 30-COUNT BOTTLES, FY24 |
| VA531C15064 | ACTELION PHARMACEUTICALS US, INC. | Department of Veterans Affairs | $58.63K | 2010-10-01 | 2011-09-30 | 325412 | BOSENTAN PRESCRIPTION MEDICATION |